Bayesian Capital Management, LP Trans Medics Group, Inc. Transaction History
Bayesian Capital Management, LP
- $582 Million
- Q1 2025
A detailed history of Bayesian Capital Management, LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,855 shares of TMDX stock, worth $1.61 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
11,855Holding current value
$1.61 Million% of portfolio
0.14%Shares
7 transactions
Others Institutions Holding TMDX
# of Institutions
338Shares Held
32.1MCall Options Held
852KPut Options Held
690K-
Vanguard Group Inc Valley Forge, PA3.57MShares$485 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL3.11MShares$422 Million0.06% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$359 Million0.01% of portfolio
-
State Street Corp Boston, MA1.31MShares$177 Million0.0% of portfolio
-
Fil LTD Hamilton, D01.23MShares$166 Million0.09% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.32B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...